<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cancer_Breast.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:24 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1175008">
<meta name="Category" content="Concern">
<meta name="Article" content="Cancer_Breast">
<title>C&#225;ncer Mamario-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">C&#225;ncer Mamario</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Cancer_Breast.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in
women. A pooled analysis of cohort studies. <em>JAMA</em> 1998;279:535&#8211;40.</li>

<li class="Ref">Garland M, Hunter DJ, Colditz GA, et al. Alcohol consumption in relation to
breast cancer risk in a cohort of United States women 25&#8211;42 years of age. <em>Cancer
Epidemiol Biomarkers Prev</em> 1999;8:1017&#8211;21.</li>

<li class="Ref">Purohit V. Moderate alcohol consumption and estrogen levels in postmenopausal
women: a review. <em>Alcohol Clin Exp Res</em> 1998;22:994&#8211;7.</li>

<li class="Ref">Ginsburg ES, Mello NK, Mendelson JH, et al. Effects of alcohol ingestion on
estrogens in postmenopausal women. <em>JAMA</em> 1996;276:1747&#8211;51.</li>

<li class="Ref">Becker U, Gluud C, Bennet P, et al. Effect of alcohol and glucose infusion on
pituitary-gonadal hormones in normal females. <em>Drug Alcohol Depend</em>
1988;22:141&#8211;9.</li>

<li class="Ref">Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake
and the risk of breast cancer. <em>JAMA</em> 1999;281:1632&#8211;7.</li>

<li class="Ref">Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake
and the risk of breast cancer. <em>JAMA</em> 1999;281:1632&#8211;7.</li>

<li class="Ref">Rao GN, Ney E, Herbert RA. Influence of diet on mammary cancer in transgenic
mice bearing an oncogene expressed in mammary tissue. <em>Breast Cancer Res Treat</em>
1997;45:149&#8211;58.</li>

<li class="Ref">Jacobs DR Jr, Marquart L, Salvin J, Kushi LH. Whole-grain intake and cancer:
an expanded review and meta-analysis. <em>Nutr Cancer</em> 1998;30:85&#8211;96.</li>

<li class="Ref">La Vecchia C, Ferraroni M, Franceschi S, et al. Fibers and breast cancer risk.
<em>Nutr Cancer</em> 1997;28:264&#8211;9.</li>

<li class="Ref">Golden BR, Woods MN, Spiegelman DL, et al. The effect of dietary fat and fiber
on serum estrogen concentrations in premenopausal women under controlled dietary conditions.
<em>Cancer</em> 1994;74(3 Suppl):1125&#8211;31.</li>

<li class="Ref">Stark AH, Switzer BR, Atwood JR, et al. Estrogen profiles in postmenopausal
African-American women in a wheat bran fiber intervention study. <em>Nutr Cancer</em>
1998;31:138&#8211;42.</li>

<li class="Ref">Baghurst PA, Rohan TE. High-fiber diets and reduced risk of breast cancer.
<em>Int J Cancer</em> 1994;56:173&#8211;6.</li>

<li class="Ref">Cohen LA. Dietary fiber and breast cancer. <em>Anticancer Res</em>
1999;19:3685&#8211;8.</li>

<li class="Ref">Frentzel-Beyme R, Chang-Claude J. Vegetarian diets and colon cancer: the
German experience. <em>Am J Clin Nutr</em> 1994;59(suppl):1143&#8211;52S.</li>

<li class="Ref">Kinlen LJ, Hermon C, Smith PG. A proportionate study of cancer mortality among
members of a vegetarian society. <em>Br J Cancer</em> 1983;48:355&#8211;61.</li>

<li class="Ref">Malter M, Schriever G, Eilber U. Natural killer cells, vitamins, and other
blood components of vegetarian and omnivorous men. <em>Nutr Cancer</em>
1989;32:271&#8211;8.</li>

<li class="Ref">Armstrong BK, Brown JB, Clarke HT, et al. Diet and reproductive hormones: a
study of vegetarian and nonvegetarian postmenopausal women. <em>J Natl Cancer Inst</em>
1981:67:761&#8211;7.</li>

<li class="Ref">Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on
breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of
associated micronutrients. <em>Eur J Cancer</em> 2000;36:636&#8211;46.</li>

<li class="Ref">Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables
and risk of breast cancer. A polled analysis of cohort studies. <em>JAMA</em>
2001;285:769&#8211;76.</li>

<li class="Ref">Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables
and risk of breast cancer. A polled analysis of cohort studies. <em>JAMA</em>
2001;285:769&#8211;76.</li>

<li class="Ref">Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of
human cancer cell proliferation than either &#945;-carotene or &#946;-carotene. <em>Nutr
Cancer</em> 1995;24:257&#8211;66.</li>

<li class="Ref">Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review
of the epidemiologic literature. <em>J Natl Cancer Inst</em> 1999;91:317&#8211;31.</li>

<li class="Ref">Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of
breast cancer. <em>J Natl Cancer Inst</em> 1998;90:1724&#8211;9.</li>

<li class="Ref">De Stefani E, Ronco A, Mendilaharsu M, et al. Meat intake, heterocyclic
amines, and risk of breast cancer : a case-control study in Uruguay. <em>Cancer Epidemiol
Biomarkers Prev</em> 1997;6:573&#8211;81.</li>

<li class="Ref">Ambrosone CB, Freudenheim JL, Sinha R, et al. Breast cancer risk, meat
consumption and <em>N</em>-acetyltransferase (<em>NAT2</em>) genetic polymorphisms. <em>Int J
Cancer</em> 1998;75:825&#8211;30.</li>

<li class="Ref">Bjeldanes LF, Morris MM, Felton JS, et al. Effect of meat composition and
cooking conditions on mutagen formation in fried ground beef. <em>J Agriculture Food Chem</em>
1983;31:18&#8211;21.</li>

<li class="Ref">Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of
breast cancer. <em>J Natl Cancer Inst</em> 1998;90:1724&#8211;9.</li>

<li class="Ref">Zheng W, Deitz AC, Campbell DR, et al. N-acetyltransferase 1 genetic
polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. <em>Cancer
Epidemiol Biomarkers Prev</em> 1999;8:233&#8211;9.</li>

<li class="Ref">Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer
risk: an ecological study. <em>Nutr Cancer</em> 1989;12:61&#8211;8.</li>

<li class="Ref">Rose DP, Connolley JM. Omega-3 fatty acids as cancer chemopreventive agents.
<em>Pharmacol Ther</em> 1999;83:217&#8211;44.</li>

<li class="Ref">Dixon JM, McDonald C, Elton RA, et al. Risk of breast cancer in women with
palpable breast cysts : a prospective study. <em>Lancet</em> 1999;353:1742&#8211;5.</li>

<li class="Ref">Tavani A, Pregnolato A, La Vecchia C, et al. Coffee consumption and the risk
of breast cancer. <em>Eur J Cancer Prev</em> 1998;7:77&#8211;82.</li>

<li class="Ref">Lubin F, Ron E, Wax Y, Modan B. Coffee and methylxanthines and breast cancer:
a case-control study. <em>J Natl Cancer Inst</em> 1985;74:569&#8211;73.</li>

<li class="Ref">Rosenberg L, Miller DR, Helmrich SP, et al. Breast cancer and the consumption
of coffee. <em>Am J Epidemiol 1985;122:391&#8211;9.</em></li>

<li class="Ref">Trichopoulou A, Katsouyanni K, Stuver S, et al. Consumption of olive and
specific food groups in relation to breast cancer risk in Greece. <em>J Natl Cancer Inst</em>
1995;87:110&#8211;6.</li>

<li class="Ref">La Vecchia C, Negri E, Franceschi S, et al. Olive oil, other dietary fats, and
the risk of breast cancer (Italy). <em>Cancer Causes Control</em> 1995;6:545&#8211;50.</li>

<li class="Ref">Martin-Moreno JM, Willett WC, Gorgojo L, et al. Dietary fat, olive oil intake
and breast cancer risk. <em>Int J Cancer</em> 1994;58:774&#8211;80.</li>

<li class="Ref">Shun-Zhang Y, Rui-Fang L, Da-Dao X, Howe GR. A case-control study of dietary
and nondietary risk factors for breast cancer in Shanghai. <em>Cancer Res</em>
1990;50:5017&#8211;21.</li>

<li class="Ref">Simonsen NR, Navajas JF-C, Martin-Moreno JM, et al. Tissue stores of
individual monounsaturated fatty acids and breast cancer: the EURAMIC study. <em>Am J Clin
Nutr</em> 1998;68:134&#8211;41.</li>

<li class="Ref">Trichopoulou A, Katsouyanni K, Stuver S, et al. Consumption of olive and
specific food groups in relation to breast cancer risk in Greece. <em>J Natl Cancer Inst</em>
1995;87:110&#8211;6.</li>

<li class="Ref">La Vecchia C, Negri E, Franceschi S, et al. Olive oil, other dietary fats, and
the risk of breast cancer (Italy). <em>Cancer Causes Control</em> 1995;6:545&#8211;50.</li>

<li class="Ref">Martin-Moreno JM, Willett WC, Gorgojo L, et al. Dietary fat, olive oil intake
and breast cancer risk. <em>Int J Cancer</em> 1994;58:774&#8211;80.</li>

<li class="Ref">Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer
risk: an ecological study. <em>Nutr Cancer</em> 1989;12:61&#8211;8.</li>

<li class="Ref">Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect of different types and
amounts of fat on the development of mammary tumors in rodents: a review. <em>Cancer Res</em>
1997;57:3979&#8211;88.</li>

<li class="Ref">Armstrong B, Doll R. Environmental factors and cancer incidence and mortality
in different countries, with special reference to dietary practices. <em>Int J Cancer</em>
1975;15:617&#8211;31.</li>

<li class="Ref">Boyar AP, Rose DP, Loughridge JR, et al. Response to a diet low in total fat
in women with postmenopausal breast cancer: a pilot study. <em>Nutr Cancer</em>
1988;11:93&#8211;9.</li>

<li class="Ref">Bagga D, Ashley JM, Geffrey SP, et al. Effects of a very low fat, high fiber
diet on serum hormones and menstrual function. <em>Cancer</em> 1995;76:2491&#8211;6.</li>

<li class="Ref">Chlebowski RT, Blackburn GL, Buzzard IM, et al. Adherence to a dietary fat
intake reduction program in postmenopausal women receiving therapy for early breast cancer.
<em>J Clin Oncol</em> 1993;11:2072&#8211;80.</li>

<li class="Ref">Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat,
high-carbohydrate diet on radiologic features of the breast: results from a randomized trial.
<em>J Natl Cancer Inst</em>1997;89:488&#8211;96.</li>

<li class="Ref">Jain M, Miller AB, To T. Premorbid diet and the prognosis of women with breast
cancer. <em>J Natl Cancer Inst</em> 1994;86:1390&#8211;7.</li>

<li class="Ref">Herbert JR, Hurley TG, Ma Yunsheng. The effect of dietary exposures on
recurrence and mortality in early stage breast cancer. <em>Breast Cancer Res Treat</em>
1998;51:17&#8211;28.</li>

<li class="Ref">Howe GR, Hirohata T, Hislop G, et al. Dietary factors and risk of breast
cancer : combined analysis of 12 case-control studies. <em>J Natl Cancer Inst</em>
19990;82:561&#8211;9.</li>

<li class="Ref">Toniolo P, Riboli E, Protta F, et al. Calorie-providing nutrients and risk of
breast cancer. <em>J Natl Cancer Inst</em> 1989;81:278&#8211;6.</li>

<li class="Ref">Holmes MD, Hunter DH, Colditz GA, et al. Association of dietary intake of fat
and fatty acids with risk of breast cancer. <em>JAMA</em> 1999;281:914&#8211;20.</li>

<li class="Ref">Jones DY, Schatzkin A, Green SB, et al. Dietary fat and breast cancer in the
National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. <em>J Natl
Cancer Inst</em> 1987;79:465&#8211;71.</li>

<li class="Ref">Newman SC, Miller AB, Howe GR. A study of the effect of weight and dietary fat
on breast cancer survival time. <em>Am J Epidemiol</em> 1986;123:767&#8211;74.</li>

<li class="Ref">Howe GR, Friedenreich CM, Jain M, Miller AB. A cohort study of fat intake and
risk of breast cancer. <em>J Natl Cancer Inst</em> 1991;83:336&#8211;40.</li>

<li class="Ref">Trichopoulou A, Katsouyanni K, Stuver S, et al. Consumption of olive and
specific food groups in relation to breast cancer risk in Greece. <em>J Natl Cancer Inst</em>
1995;87:110&#8211;6.</li>

<li class="Ref">La Vecchia C, Negri E, Franceschi S, et al. Olive oil, other dietary fats, and
the risk of breast cancer (Italy). <em>Cancer Causes Control</em> 1995;6:545&#8211;50.</li>

<li class="Ref">Martin-Moreno JM, Willett WC, Gorgojo L, et al. Dietary fat, olive oil intake
and breast cancer risk. <em>Int J Cancer</em> 1994;58:774&#8211;80.</li>

<li class="Ref">Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer
risk: an ecological study. <em>Nutr Cancer</em> 1989;12:61&#8211;8.</li>

<li class="Ref">Jones DY, Schatzkin A, Green SB, et al. Dietary fat and breast cancer in the
National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. <em>J Natl
Cancer Inst</em> 1987;79:465&#8211;71.</li>

<li class="Ref">Newman SC, Miller AB, Howe GR. A study of the effect of weight and dietary fat
on breast cancer survival time. <em>Am J Epidemiol</em> 1986;123:767&#8211;74.</li>

<li class="Ref">Saskai S, Moracsek M, Kesteloot H. An ecological study of the relationship
between dietary fat intake and breast cancer mortality. <em>Prev Med</em>
1993;22:187&#8211;202.</li>

<li class="Ref">Armstrong B, Doll R. Environmental factors and cancer incidence and mortality
in different countries, with special reference to dietary practices. <em>Int J Cancer</em>
1975;15:617&#8211;31.</li>

<li class="Ref">Wu AH, Ziegler RG, Nomura AMY, et al. Soy intake and risk of breast cancer in
Asians and Asian Americans. <em>Am J Clin Nutr</em> 1998;68(suppl):1437&#8211;43S
[review].</li>

<li class="Ref">Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in
Asian-Americans. <em>Cancer Epidemiol Biomarkers Prev</em> 1996;5:901&#8211;6.</li>

<li class="Ref">Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a
review of the <em>in vitro</em> and <em>in vivo</em> data. <em>Nutr Cancer</em>
1994;21:113&#8211;31 [review].</li>

<li class="Ref">Messina MJ. Legumes and soybeans: overview of their nutritional profiles and
health effects. <em>Am J Clin Nutr</em> 1999;70(suppl):439&#8211;50S [review].</li>

<li class="Ref">Barnes S. <em>The chemopreventive properties of soy isoflavonoids in animal
models of breast cancer.</em> Breast Cancer Res Treat 1997;46:169&#8211;79 [review].</li>

<li class="Ref">Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein
during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring.
<em>Oncol Rep</em> 1999;6:1089&#8211;95.</li>

<li class="Ref">Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. <em>J Clin Endocrinol
Metab</em> 1999;84:4017&#8211;24.</li>

<li class="Ref">Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein
isolate on breast secretion in pre- and postmenopausal women. <em>Cancer Epidemiol Biomarkers
Prev</em> 1996;5:785&#8211;94.</li>

<li class="Ref">McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein
supplementation on epithelial proliferation in the histologically normal human breast. <em>Am
J Clin Nutr</em> 1998;68(suppl):1431&#8211;6S.</li>

<li class="Ref">Barnes S. <em>The chemopreventive properties of soy isoflavonoids in animal
models of breast cancer.</em> Breast Cancer Res Treat 1997;46:169&#8211;79 [review].</li>

<li class="Ref">Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein
during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring.
<em>Oncol Rep</em> 1999;6:1089&#8211;95.</li>

<li class="Ref">Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one
month on steroid hormones in premenopausal women: implications for breast cancer risk
reduction. <em>Cancer Epidemiol Biomarkers Prev</em> 1996;5:63&#8211;70.</li>

<li class="Ref">Nagato C, Takatsuka N, Inaba S, et al. Effect of soymilk consumption on serum
estrogen concentrations in premenopausal Japanese women. <em>J Natl Cancer Inst</em>
1998;90:1830&#8211;5.</li>

<li class="Ref">Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. <em>J Clin Endocrinol
Metab</em> 1999;84:4017&#8211;24.</li>

<li class="Ref">Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein
isolate on breast secretion in pre- and postmenopausal women. <em>Cancer Epidemiol Biomarkers
Prev</em> 1996;5:785&#8211;94.</li>

<li class="Ref">McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein
supplementation on epithelial proliferation in the histologically normal human breast. <em>Am
J Clin Nutr</em> 1998;68(suppl):1431&#8211;6S.</li>

<li class="Ref">Barnes S. <em>The chemopreventive properties of soy isoflavonoids in animal
models of breast cancer.</em> Breast Cancer Res Treat 1997;46:169&#8211;79 [review].</li>

<li class="Ref">Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein
during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring.
<em>Oncol Rep</em> 1999;6:1089&#8211;95.</li>

<li class="Ref">Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. <em>J Clin Endocrinol
Metab</em> 1999;84:4017&#8211;24.</li>

<li class="Ref">Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein
isolate on breast secretion in pre- and postmenopausal women. <em>Cancer Epidemiol Biomarkers
Prev</em> 1996;5:785&#8211;94.</li>

<li class="Ref">McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein
supplementation on epithelial proliferation in the histologically normal human breast. <em>Am
J Clin Nutr</em> 1998;68(suppl):1431&#8211;6S.</li>

<li class="Ref">Messina MJ. Legumes and soybeans: overview of their nutritional profiles and
health effects. <em>Am J Clin Nutr</em> 1999;70(suppl):439&#8211;50S [review].</li>

<li class="Ref">Barnes S. <em>The chemopreventive properties of soy isoflavonoids in animal
models of breast cancer.</em> Breast Cancer Res Treat 1997;46:169&#8211;79 [review].</li>

<li class="Ref">Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein
during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring.
<em>Oncol Rep</em> 1999;6:1089&#8211;95.</li>

<li class="Ref">Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. <em>J Clin Endocrinol
Metab</em> 1999;84:4017&#8211;24.</li>

<li class="Ref">Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein
isolate on breast secretion in pre- and postmenopausal women. <em>Cancer Epidemiol Biomarkers
Prev</em> 1996;5:785&#8211;94.</li>

<li class="Ref">McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein
supplementation on epithelial proliferation in the histologically normal human breast. <em>Am
J Clin Nutr</em> 1998;68(suppl):1431&#8211;6S.</li>

<li class="Ref">Messina M, Barnes S. The role of soy products in reducing risk of cancer. <em>
J Natl Cancer Inst</em> 1991;83:541&#8211;6 [review].</li>

<li class="Ref">Burley VJ. Sugar consumption and human cancer in sites other than the
digestive tract. Eur J Cancer Prev 1998;7:253&#8211;77 [review].</li>

<li class="Ref">Decarli A, Favero A, La Vecchia C, et al. Macronutrients, energy intake, and
breast cancer risk: implications from different models. <em>Epidemiology</em>
1997;8:425&#8211;8.</li>

<li class="Ref">Marcus PM, Newman B, Moorman PG, et al. Physical activity at age 12 and adult
breast cancer risk (United States). <em>Cancer Causes Control</em> 1999;10:293&#8211;302.</li>

<li class="Ref">Bullen BA, Skrinar GS, Beitins IZ, et al. Induction of menstrual disorders by
strenuous exercise in untrained women. <em>N Engl J Med</em> 1985;312:1349&#8211;53.</li>

<li class="Ref">Rockhill B, Willett WC, Hunter DJ, et al. A prospective study of recreational
physical activity and breast cancer risk. <em>Arch Intern Med</em> 1999;159:2290&#8211;6.</li>

<li class="Ref">Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast
cancer. <em>N Engl J Med</em> 1997;336:1269&#8211;75.</li>

<li class="Ref">Gammon MD, Schoenberg JB, Britton JA, et al. Recreational physical activity
and breast cancer risk among women under age 45 years. <em>Am J Epidemiol</em>
1998;147:273&#8211;80.</li>

<li class="Ref">Gram IT, Funkhouser E, Tabar L. Moderate physical activity in relation to
mammographic patterns. <em>Cancer Epidemiol Biomarkers Prev</em> 1999;8:117&#8211;22.</li>

<li class="Ref">Segar ML, Katch VL, Roth RS, et al. The effect of aerobic exercise on
self-esteem and depressive and anxiety symptoms among breast cancer survivors. <em>Oncol Nurs
Forum</em> 1998;25:107&#8211;13.</li>

<li class="Ref">Johnson KC, Hu J, Mao Y, &amp; The Canadian Cancer Registries Epidemiology
Research Group. Passive and active smoking and breast cancer risk in Canada, 1994&#8211;7.
<em>Cancer Causes Control</em> 2000;11:211&#8211;21.</li>

<li class="Ref">London SJ, Colditz GA, Stampfer JM, et al. Prospective study of smoking and
the risk of breast cancer. <em>J Natl Cancer Inst</em> 1989;81:1625&#8211;31.</li>

<li class="Ref">Gammon MD, Schoenberg JB, Teitelbaum SL, et al. Cigarette smoking and breast
cancer risk among young women (United States). <em>Cancer Causes Control</em>
1998;9:583&#8211;90.</li>

<li class="Ref">Lash TJ, Aschengrau A. Active and passive cigarette smoking and the occurrence
of breast cancer. <em>Am J Epidemiol</em> 1999;149:5&#8211;12.</li>

<li class="Ref">Gallo JJ, Armenian HK, Ford DE. Major depression and cancer: the 13-year
follow-up of the Baltimore Epidemiologic Catchment Area sample (United States). <em>Cancer
Causes Control</em> 2000;11:751&#8211;8.</li>

<li class="Ref">Chen CC, David AS, Nunnerley H, et al. Adverse life events and breast cancer:
case-control study. <em>BMJ</em> 1995;311:1527&#8211;30.</li>

<li class="Ref">Geyer S. Life events prior to manifestation of breast cancer: a limited
prospective study covering eight years before diagnosis. <em>J Psychosomatic Res</em>
1991;35:355&#8211;63.</li>

<li class="Ref">Protheroe D, Turvey K, Horgan K, et al. Stressful life events and difficulties
and onset of breast cancer: case-control study. <em>BMJ</em> 1999;319:1027&#8211;30.</li>

<li class="Ref">Ramirez AJ, Craig TK, Watson JP, et al. Stress and relapse of breast cancer.
<em>BMJ</em> 1989;298:291&#8211;3.</li>

<li class="Ref">Roberts FD, Newcomb PA, Trentham-Dietz A, Storer BE. Self-reported stress and
risk of breast cancer. <em>Cancer</em> 1996;77:1089&#8211;93.</li>

<li class="Ref">Barraclough J, Pinder P, Cruddas M, et al. Life events and breast cancer
prognosis. <em>BMJ</em> 1992;304:1078&#8211;81.</li>

<li class="Ref">Tross S, Herndon J II, Korzun A, et al. Psychological symptoms and
disease-free and overall survival in women with stage II breast cancer. <em>J Natl Cancer
Inst</em> 1996;88:661&#8211;7.</li>

<li class="Ref">Andersen BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune response
after surgical treatment for regional breast cancer. <em>J Natl Cancer Inst</em>
1998;90:30&#8211;6.</li>

<li class="Ref">Levy SM, Herberman RB, Whiteside T, et al. Perceived social support and tumor
estrogen/progesterone receptor status as predictors of natural killer cell activity in breast
cancer patients. <em>Psychosomatic Med</em> 1990;52:73&#8211;85.</li>

<li class="Ref">Andersen BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune response
after surgical treatment for regional breast cancer. <em>J Natl Cancer Inst</em>
1998;90:30&#8211;6.</li>

<li class="Ref">Levy SM, Herberman RB, Whiteside T, et al. Perceived social support and tumor
estrogen/progesterone receptor status as predictors of natural killer cell activity in breast
cancer patients. <em>Psychosomatic Med</em> 1990;52:73&#8211;85.</li>

<li class="Ref">Mausell E, Brisson J, Desch&#234;nes L. Social support and survival among
women with breast cancer. <em>Cancer</em> 1995;76:631&#8211;7.</li>

<li class="Ref">Pettingall KW, Morris T, Greer S, Haybittle JL. Mental attitudes to cancer: an
additional prognostic factor. <em>Lancet</em> 1985;i:750.</li>

<li class="Ref">Greer S, Morris T, Pettingale KW, Haybittle JL. Psychological response to
breast cancer and 15-year outcome. <em>Lancet</em> 1990;335:49&#8211;50 [letter].</li>

<li class="Ref">Watson M, Haviland JS, Greer S, et all. Influence of psychological response on
survival in breast cancer: a population-based cohort study. <em>Lancet</em>
1999;354:1331&#8211;6.</li>

<li class="Ref">Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for
patients with cancer: a prospective randomised trial. <em>Lancet</em>
1992;304:675&#8211;80.</li>

<li class="Ref">Simonton OC, Matthews-Simonton S. Cancer and stress. Counseling the cancer
patients. <em>Med J Aust</em> 1981;1:679&#8211;83.</li>

<li class="Ref">Grossarth-Maticek R, Eysenck HJ. Length of survival and lymphocyte percentage
in women with mammary cancer as a function of psychotherapy. <em>Psychol Rep</em>
1989;65:315&#8211;21.</li>

<li class="Ref">Spiegel D, Bloom JR, Kraemer HC, Gottheil. Effect of psychosocial treatment on
survival of patients with metastatic breast cancer. <em>Lancet</em> 1989;ii:888&#8211;91.</li>

<li class="Ref">Bridge LR, Benson P, Pietroni PC, Priest RG. Relaxation and imagery in the
treatment of breast cancer. <em>BMJ</em> 1988;297:1169&#8211;72.</li>

<li class="Ref">Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast
carcinoma pain. <em>Psychosom Med</em> 1983;45:333&#8211;9.</li>

<li class="Ref">Gellert GA, Maxwell RM, Siegel BS. Survival of breast cancer patients
receiving adjunctive psychosocial support therapy: a 10-year follow-up study. <em>J Clin
Oncol</em> 1993;11:66&#8211;9.</li>

<li class="Ref">Peacock SL, White E, Daling JR, et al. Relation between obesity and breast
cancer in young women. <em>Am J Epidmeiol</em> 1999;149:339&#8211;46.</li>

<li class="Ref">Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast
cancer risk. <em>J Natl Cancer Inst</em> 2000;92:266&#8211;9.</li>

<li class="Ref">Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake
and the risk of breast cancer. <em>JAMA</em> 1999;281:1632&#8211;7.</li>

<li class="Ref">Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake
and the risk of breast cancer. <em>JAMA</em> 1999;281:1632&#8211;7.</li>

<li class="Ref">Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for
cancer death in middle-aged men. <em>Nutr Cancer</em> 1987;10:221&#8211;9.</li>

<li class="Ref">Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of
cancer among Finnish men and women. <em>J Natl Cancer Inst</em> 1990;82:864&#8211;8.</li>

<li class="Ref">Kok FJ, deBruijn AM, Hofman A, et al. Is serum selenium a risk factor for
cancer in men only? <em>Am J Epidemiol</em> 1987;125:12&#8211;6.</li>

<li class="Ref">Brock KE, Gridley G, Morris JS, Willett WC. Serum selenium level in relation
to in situ cervical cancer in Australia. <em>J Natl Cancer Inst</em> 1991;83:292&#8211;3.</li>

<li class="Ref">Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of
cancer among Finnish men and women. <em>J Natl Cancer Inst</em> 1990;82:864&#8211;8.</li>

<li class="Ref">Kok FJ, deBruijn AM, Hofman A, et al. Is serum selenium a risk factor for
cancer in men only? <em>Am J Epidemiol</em> 1987;125:12&#8211;6.</li>

<li class="Ref">Hunter DJ, Morris JS, Stampfer MJ, et al. A prospective study of selenium
status and breast cancer risk. <em>JAMA</em> 1990;264:1128&#8211;31.</li>

<li class="Ref">Helzlsouer KJ, Alberg AJ, Norjus EP, et al. Prospective study of serum
micronutrients and ovarian cancer. <em>J Natl Cancer Inst</em> 1996;88:32&#8211;7.</li>

<li class="Ref">Vinceti M, Rovesti S, Gabrielli C, et al. Cancer mortality in a residential
cohort exposed to environmental selenium through drinking water. <em>J Clin Epidemiol</em>
1995;48:1091&#8211;7.</li>

<li class="Ref">Garland M, Morris JS, Stampfer MJ, et al. Prospective study of toenail
selenium levels and cancer among women. <em>J Natl Cancer Inst</em>
1995;87:497&#8211;505.</li>

<li class="Ref">Clark LC, Alberts DS. Selenium and cancer: risk or protection? <em>J Natl
Cancer Inst</em> 1995;87:473&#8211;5 [editorial].</li>

<li class="Ref">Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation
for cancer prevention in patients with carcinoma of the skin. <em>JAMA</em>
1996;276:1957&#8211;63.</li>

<li class="Ref">Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation
for cancer prevention in patients with carcinoma of the skin. <em>JAMA</em>
1996;276:1957&#8211;63.</li>

<li class="Ref">Thompson HJ, Meeker LD, Becci PJ, Kokoska S. Effect of short-term feeding of
sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat.
<em>Cancer Res</em> 1982;42:4954&#8211;8.</li>

<li class="Ref">Schrauzer GN, Ishmael D. Effects of selenium and of arsenic on the genesis of
spontaneous mammary tumors in inbred C3H mice. <em>Ann Clin Lab Sci</em>
1974;4:441&#8211;7.</li>

<li class="Ref">Schrauzer GN, Molenaar T, Mead S, et al. Selenium in the blood of Japanese and
American women with and without breast cancer and fibrocystic disease. <em>Jpn J Cancer
Res</em> (Gann) 1985;76:374&#8211;7.</li>

<li class="Ref">McConnell KP, Jager RM, Bland KI, Blotcky AJ. The relationship of dietary
selenium and breast cancer. <em>J Surg Oncol</em> 1980;15:67&#8211;70.</li>

<li class="Ref">Hunter DJ, Morris JS, Stampfer MJ, et al. A prospective study of selenium
status and breast cancer risk. <em>JAMA</em> 1990;264:1128&#8211;31.</li>

<li class="Ref">Van&#8217;t Veer P, van der Wielen RPG, Kok FJ, et al. Selenium in diet,
blood, and toenails in relation to breast cancer: a case-control study. <em>Am J
Epidemiol</em> 1990;131:987&#8211;94.</li>

<li class="Ref">Van den Brandt PA, Goldbohm A, van&#8217;t Veer P, et al. Toenail selenium
levels and the risk of breast cancer. <em>Am J Epidemiol</em> 1994;140:20&#8211;6.</li>

<li class="Ref">Van Noord PA, Collette HJ, Maas MJ, de Waard F. Selenium levels in nails of
premenopausal breast cancer patients assessed prediagnostically in a cohort-nested
case-referent study among women screened in the DOM project. <em>Int J Epidemiol</em>
1987;16:318&#8211;22.</li>

<li class="Ref">Garland M, Willett WC, Manson JE, Hunter DJ. Antioxidant micronutrients and
breast cancer. <em>J Am Coll Nutr</em> 1993;12400&#8211;11 [review].</li>

<li class="Ref">Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation
for cancer prevention in patients with carcinoma of the skin. <em>JAMA</em>
1996;276:1957&#8211;63.</li>

<li class="Ref">M&#228;nnist&#246; S, Alfthan G, Virtanen M, et al. Toenail selenium and
breast cancer&#8211;&#8211;a case-control study in Finland. <em>Eur J Clin Nutr</em>
2000;54:98&#8211;103.</li>

<li class="Ref">Torun M, Akgul S, Sargin H. Serum vitamin E level in patients with breast
cancer. <em>J Clin Pharmacol Ther</em> 1995;20:173&#8211;8.</li>

<li class="Ref">Wald NJ, Boreham J, Hawward JL, et al. Plasma retinol, &#223;-carotene and
vitamin E levels in relation to the future risk of breast cancer. <em>Br J Cancer</em>
1984;49:321&#8211;4.</li>

<li class="Ref">Kimmick GG, Bell RA, Bostick RM. Vitamin E and breast cancer: a review. <em>
Nutr Cancer</em> 1997;27:109&#8211;17.</li>

<li class="Ref">Gerber M, Richardson S, Crastes de Paulet P, et al. Relationship between
vitamin E and polyunsaturated fatty acids in breast cancer. <em>Cancer</em>
1989;64:2374&#8211;53.</li>

<li class="Ref">Gerber M, Cavallo F, Marubini E, et al. Liposoluble vitamins and lipid
parameters in breast cancer. A joint study in northern Italy and southern France. <em>Int J
Cancer</em> 1988;42:489&#8211;94.</li>

<li class="Ref">Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of
vitamins C, E, and A and the risk of breast cancer. <em>N Engl J Med</em>
1993;329:234&#8211;40.</li>

<li class="Ref">Knekt P. Serum vitamin E level and risks of female cancers. <em>Int J
Epidemiol</em> 1988;17:281&#8211;8.</li>

<li class="Ref">Pussinen PJ, Lindner H, Glatter O, et al. Lipoprotein-associated
alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and
HBL-100 breast cancer cells. <em>Biochim Biophys Acta</em> 2000;1485:129&#8211;44.</li>

<li class="Ref">Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the
USSR. <em>Int J Epidemiol</em> 1990;19:820&#8211;4.</li>

<li class="Ref">Anzano MA, Smith JM, Uskokovic, et al.
1&#945;,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24&#8211;5531), a new
deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. <em>Cancer Res</em>
1994;54:1653&#8211;6.</li>

<li class="Ref">Demdirpence E, Balaguer P, Trousse F, et al. Antiestrogenic effects of
all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the
estrogen response element level but through different molecular mechanisms. <em>Cancer
Res</em> 1994;54:1458&#8211;64.</li>

<li class="Ref">John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the
NHANES I Epidemiologic follow-up study, 1971&#8211;1975 to 1992. <em>Cancer Epidemiol
Biomarkers Prev</em> 1999;8:399&#8211;406.</li>

<li class="Ref">Vink-van Wijngaarden T, Pols HA, Buurman CJ, et al. Inhibition of breast
cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. <em>Cancer
Res</em> 1994;54:5711&#8211;7.</li>

<li class="Ref">James SY, Merceer E, Brady M, et al. ERB1089, a synthetic analogue of vitamin
D, induces apoptosis in breast cancer cells in vivo and in vitro. <em>Br J Pharmacol</em>
1998;125:953&#8211;62.</li>

<li class="Ref">Eisman JA, Barkla DH, Tutton PJM. Suppression of in vitro growth of human
cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. <em>Cancer</em> Res
1987;47:21&#8211;5.</li>

<li class="Ref">Ravid A, Rocker D, Machlenkin A, et al. 1,25-dihydroxyvitamin D3 enhances the
susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. <em>Cancer</em>
Res 1999;59:862&#8211;7.</li>

<li class="Ref">Bower M, Colston KW, Stein RC, et al. Topical calcipotriol treatment in
advanced breast cancer. <em>Lancet</em> 1991;337:701&#8211;2.</li>

<li class="Ref">Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling
breast cancer cell proliferation. <em>Lancet</em> 1989;I:188&#8211;91.</li>

<li class="Ref">Eisman JA, Suva LJ, Martin TJ. Significance of 1,25-dihydroxyvitamin D3
receptor in primary breast cancer. <em>Cancer Res</em> 1986;46:5406&#8211;8.</li>

<li class="Ref">Freake HC, Abeyasekera G, Iwasaki J, et al. Measurement of
1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and
clinical indices. <em>Cancer</em> Res 1984;44:1677&#8211;81.</li>

<li class="Ref">Cos S, Fern&#225;ndez R, G&#252;&#233;zmes A, S&#225;nchez-Barcel&#243; EJ.
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer
cells. <em>Cancer Res</em> 1998;58:4383&#8211;90.</li>

<li class="Ref">Mediavilla MD, Cos S, S&#225;nchez-Barcel&#243; EJ. Melatonin increases p53
and p21 WAF1 expression in MCF-7 human breast cancer cells in vitro. <em>Life Sci</em>
1999;65:415&#8211;20.</li>

<li class="Ref">Baldwin WS, Travlos GS, Risinger JI, Barrett JC. Melatonin does not inhibit
estradiol-stimulated proliferation in MCF-7 and BG-1 cells. <em>Carcinogenesis</em>
1998;19:1895&#8211;1900.</li>

<li class="Ref">Lissoni P, Barmo S. Meregalli S, et al. Modulation of cancer endocrine therapy
by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer
patients progressing under tamoxifen alone. <em>Br J Cancer</em> 1995;71:854&#8211;6.</li>

<li class="Ref">Neri B, De Leonardis V, Gemelli MT, et al. Melatonin as biological response
modifier in cancer patients. <em>Anticancer Res</em> 1998;18:1329&#8211;32.</li>

<li class="Ref">Lissoni P, Barni S, Crispino S, et al. Endocrine and immune effects of
melatonin therapy in metastatic cancer patients. <em>Eur J Cancer Clin Oncol</em>
1989;25:789&#8211;95.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. A randomized study with the pineal
hormone melatonin versus supportive care alone in patients with brain metastases due to solid
neoplasms. <em>Cancer</em> 1994;73:699&#8211;701.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. Randomized study with the pineal
hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant
to a first-line chemotherapy containing cisplatin. <em>Oncology</em> 1992;49:336&#8211;9.</li>

<li class="Ref">Lissoni P, Paolorossi F, Tancini G, et al. Is there a role for melatonin in
the treatment of neoplastic cachexia? <em>Eur J Cancer</em> 1996;32A:1340&#8211;3.</li>

<li class="Ref">Lissoni P, Barni S, Tancini G, et al. A randomised study with subcutaneous
low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in
advanced solid neoplasms other than renal cancer and melanoma. <em>Br J Cancer</em>
1994;69:196&#8211;9.</li>

<li class="Ref">Lissoni P, Brivio F, Ardizzoia A, et al. Subcutaneous therapy with low-dose
interlekin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low
performance status. <em>Tumori</em> 1993;79:401&#8211;4.</li>

<li class="Ref">Aldeghi R, Lissoni P, Barni S, et al. Low-dose interlekin-2 subcutaneous
immunotherapy in association with the pineal hormone melatonin as a first-line therapy in
locally advanced or metastatic hepatocellular carcinoma. <em>Eur J Cancer</em>
1994;30A:167&#8211;70.</li>

<li class="Ref">Lissoni P, Paolorossi F, Tancini G, et al. A phase II study of tamoxifen plus
melatonin in metastatic solid tumour patients. <em>Br J Cancer</em> 1996;74:1466&#8211;8.</li>

<li class="Ref">Lissoni P, Barni S, Mandal&#224;, et al. Decreased toxicity and increased
efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour
patients with poor clinical status. <em>Eur J Cancer</em> 1999;35:1688&#8211;92.</li>

<li class="Ref">Lissoni P, Brivio O, Brivio F, et al. Adjuvant therapy with the pineal hormone
melatonin in patients with lymph node relapse due to malignant melanoma. <em>J Pineal Res</em>
1996;21:239&#8211;42.</li>

<li class="Ref">Neri B, Fiorelli C, Moroni F, et al. Modulation of human lymphoblastoid
interferon activity by melatonin in metastatic renal cell carcinoma. <em>Cancer</em>
1994;73:315&#8211;9.</li>

<li class="Ref">Jolliet P, Simon N, Barr J, et al. Plasma coenzyme Q10 concentrations in
breast cancer: prognosis and therapeutic consequences. <em>Int J Clin Pharmacol Ther</em>
1998;36:506&#8211;9.</li>

<li class="Ref">Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of
breast cancer in &#8220;high risk&#8221; patients supplemented with nutritional antioxidants,
essential fatty acids and CoQ10. Eighth International Symposium on the Biomedical and Clinical
Aspects of Coenzyme Q10, Stockholm, Sweden, November, 1993.</li>

<li class="Ref">Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of
breast cancer in &#8216;high risk&#8217; patients supplemented with nutritional antioxidants,
essential fatty acids and coenzyme Q10. <em>Molec Aspects Med</em>
1994;5(Suppl):S231&#8211;40.</li>

<li class="Ref">Lockwood K., Moesgaard S., Folkers K. Partial and complete regression of
breast cancer in patients in relation to dosage of coenzyme Q10. <em>Biochem Biophys Res
Comm</em> 1994;199:1504&#8211;8.</li>

<li class="Ref">Lockwood K., Moesgaard S., Yamamoto T., Folkers K. Progress on therapy of
breast cancer with vitamin Q10 and the regression of metastases. <em>Biochem Biophys Res
Comm</em> 1995;212:172&#8211;7.</li>

<li class="Ref">Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of
breast cancer in &#8216;high risk&#8217; patients supplemented with nutritional antioxidants,
essential fatty acids and coenzyme Q10. <em>Molec Aspects Med</em>
1994;5(Suppl):S231&#8211;40.</li>

<li class="Ref">Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of
breast cancer in &#8220;high risk&#8221; patients supplemented with nutritional antioxidants,
essential fatty acids and CoQ10. Eighth International Symposium on the Biomedical and Clinical
Aspects of Coenzyme Q10, Stockholm, Sweden, November, 1993.</li>

<li class="Ref">Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of
breast cancer in &#8216;high risk&#8217; patients supplemented with nutritional antioxidants,
essential fatty acids and coenzyme Q10. <em>Molec Aspects Med</em>
1994;5(Suppl):S231&#8211;40.</li>

<li class="Ref">Lockwood K., Moesgaard S., Folkers K. Partial and complete regression of
breast cancer in patients in relation to dosage of coenzyme Q10. <em>Biochem Biophys Res
Comm</em> 1994;199:1504&#8211;8.</li>

<li class="Ref">Lockwood K., Moesgaard S., Yamamoto T., Folkers K. Progress on therapy of
breast cancer with vitamin Q10 and the regression of metastases. <em>Biochem Biophys Res
Comm</em> 1995;212:172&#8211;7.</li>

<li class="Ref">Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans
following consumption of indole-3-carbinol. <em>Nutr Cancer</em> 1991;16:59&#8211;66.</li>

<li class="Ref">Wattenberg LW, Loub WD. Inhibition of polycyclic aromatic hydrocarbon-induced
neoplasia by naturally occurring indoles. <em>Cancer Res</em> 1978;38:1410&#8211;3.</li>

<li class="Ref">Cover CM, Hsieh SJ, Cram EJ, et al. Indole-3-carbinal and tamoxifen cooperate
to arrest the cell cycle of MCF-7 breast cancer cells. <em>Cancer Res</em>
1999;59:1244&#8211;51.</li>

<li class="Ref">Riby JE, Chang GH, Firestone GL, Bjeldanes LF. Ligand-independent activation
of estrogen receptor function by 3, 3&#8217;-diindolylmethane in human breast cancer cells.
<em>Biochem Pharmacol</em> 2000;60:167&#8211;77.</li>

<li class="Ref">McDougal A, Sethi Gupta M, Ramamoorthy K, et al. Inhibition of
carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by
symmetrical dihalo-substituted analogs of diindolylmethane. <em>Cancer Lett</em>
2000;151:169&#8211;79.</li>

<li class="Ref">Walaszek Z, Szemraj J, Hanausek M, et al. D-glucaric acid content of various
fruits and vegetables and cholesterol-lowering effects of dietary D-glucarate in the rat. <em>
Nutr Res</em> 1996;16:673&#8211;81.</li>

<li class="Ref">Heerdt AS, Young CW, Borgen PI. Calcium glucarate as a chemopreventive agent
in breast cancer. <em>Isr J Med Sci</em> 1995;31:101&#8211;5.</li>

<li class="Ref">Abou-Issa HM, Duruibe VA, Minton JP, et al. Putative metabolites derived from
dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act
synergistically to inhibit the induction of rat mammary tumors by
7,12-dimethylbenz[a]anthracene. <em>Proc Natl Acad Sci</em> 1988;85:4181&#8211;4.</li>

<li class="Ref">Shamsuddin AM. Metabolism and cellular functions of IP6:a a review. <em>
Anticancer Res</em> 1999;19:3733&#8211;6.</li>

<li class="Ref">Dorant E, van der Brandt PA, Goldbohm RA. Allium vegetable consumption, garlic
supplement intake and female breast carcinoma incidence. <em>Br Cancer Res Treat</em>
1995;33:163&#8211;70.</li>

<li class="Ref">Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective
factors for breast cancer: A French case-control study. <em>Eur J Epidemiol</em>
1998;14:737&#8211;47.</li>

<li class="Ref">Pedrinaci S, Algarra I, Garrido F. Protein-bound polysaccharide (PSK) induces
cytotoxic activity in the NKL human natural killer cell line. <em>Int J Clin Lab Res</em>
1999;29:135&#8211;40.</li>

<li class="Ref">Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment.
<em>Altern Med Rev</em> 2000;5:4&#8211;27 [review].</li>

<li class="Ref">Maehara Y, Moriguchi S, Sakaguchi Y, et al. Adjuvant chemotherapy enhances
long-term survival of patients with advanced gastric cancer following curative resection. <em>
J Surg Oncol</em> 1990;45:169&#8211;72.</li>

<li class="Ref">Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment.
<em>Altern Med Rev</em> 2000;5:4&#8211;27 [review].</li>

<li class="Ref">Kaibara N, Soejima K, Nakamura T, et al. Postoperative long-term chemotherapy
for advanced gastric cancer. <em>Jpn J Surg</em> 1976;6:54&#8211;9.</li>

<li class="Ref">Niimoto M, Hattori T, Tamada R, et al. Postoperative adjuvant
immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data
on 579 patients followed for five years. <em>Jpn J Surg</em> 1988;18:681&#8211;6.</li>

<li class="Ref">Nakazato H, Koike A, Saji S, et al. Efficacy of immunochemotherapy as adjuvant
treatment after curative resection of gastric cancer. <em>Lancet</em>
1994;343:1122&#8211;6.</li>

<li class="Ref">Ogoshi K, Satou H, Isono K, et al. Possible predictive markers of
immunotherapy in esophageal cancer: retrospective analysis of a randomized study. <em>Cancer
Invest</em> 1995;13:363&#8211;9.</li>

<li class="Ref">Hayakawa K, Mitsuhashi N, Saito Y, et al. Effect of Krestin (PSK) as adjuvant
treatment on the prognosis after radical radiotherapy in patients with non-small cell lung
cancer. <em>Anticancer Res</em> 1993;13:1815&#8211;20.</li>

<li class="Ref">Kondo M, Torisu M. Evaluation of an anticancer activity of a protein-bound
polysaccharide PS-K (Krestin). In: Torisu M, Yoshida T (eds). <em>Basic Mechanisms and
Clinical Treatment of Tumor Metastasis</em>. New York: Academic Press, 1985,
623&#8211;36.</li>

<li class="Ref">Toi M, Hattori T, Akagi M, et al. Randomized adjuvant trial to evaluate the
addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-year
results from the Nishi-Nippon Group of the Adjuvant Chemoendorine Therapy for Breast Cancer
Organization. <em>Cancer</em> 1992;70:2475&#8211;83.</li>

<li class="Ref">Iino Y, Yokoe T, Maemura M, et al. Immunochemotherapies <em>versus</em>
chemotherapy as adjuvant treatment after curative resection of operable breast cancer. <em>
Anticancer Res</em> 1995;15:2907&#8211;12.</li>

<li class="Ref">Morimoto T, Ogawa M, Orita K, et al. Postoperative adjuvant randomised trial
comparing chemo-endocrine therapy, chemotherapy and immunotherapy for patients with stage II
breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant
Chemo-endocrine Therapy for Breast Cancer (ACETBC) of Japan. <em>Eur J Cancer</em>
1996;32A:235&#8211;42.</li>

<li class="Ref">Gvamichava AR, Khatiashvili TM, Khudzhadze RG, et al. First results of the use
of <em>Eleutherococcus</em> in the combined treatment of breast carcinoma. <em>Lek Sredestva
Dal&#8217;nego Vostoka</em> 1966;7:231&#8211;5 [in Russian].</li>

<li class="Ref">Kupin VI, Polevaia YeB, Sorokin AM. Stimulation of the immunological
reactivity of cancer patients by <em>Eleutherococcus</em> extract. <em>Vopr Onkol</em>
1986;32:21&#8211;6 [in Russian].</li>

<li class="Ref">Gvamichava AR, Khatiashvili TM, Khudzhadze RG, et al. First results of the use
of <em>Eleutherococcus</em> in the combined treatment of breast carcinoma. <em>Lek Sredestva
Dal&#8217;nego Vostoka</em> 1966;7:231&#8211;5 [in Russian].</li>

<li class="Ref">Kupin VI, Polevaia YeB, Sorokin AM. Stimulation of the immunological
reactivity of cancer patients by <em>Eleutherococcus</em> extract. <em>Vopr Onkol</em>
1986;32:21&#8211;6 [in Russian].</li>

<li class="Ref">Kleijnen J, Knipschild P. Mistletoe treatment for cancer. Review of controlled
trials in humans. <em>Phytomedicine</em> 1994;1:255&#8211;60 [review].</li>

<li class="Ref">Dold U, Edler L, M&#228;urer HC, et al. <em>Supplemental Cancer Therapy for
Advanced Non-Small Cell Bronchial Carcinoma</em>. Stuttgart: Georg Thieme Verlag, 1991.</li>

<li class="Ref">Douwes FR, Kalden M, Frank G, Holzhauer P. Treatment of advanced colorectal
carcinomas. <em>Deutsch Z Onkol</em> 1988;21:63&#8211;7 [in German].</li>

<li class="Ref">Kjaer M. Mistletoe (Iscador) therapy in stage IV renal adenocarcinoma. <em>
Acta Oncol</em> 1988;28:489&#8211;94.</li>

<li class="Ref">Steuer-Vogt MK, Bonkowsky V, Ambrosch P, et al. The effect of an adjuvant
mistletoe treatment programme in resected head and neck cancer patients: a randomised
controlled clinical trial. <em>Eur J Cancer</em> 2001;37:23&#8211;31.</li>

<li class="Ref">Heiny BM. Adjuvant treatment with standardized mistletoe extract reduces
leukopenia and improves the quality of life of patients with advanced carcinoma of the breast
receiving palliative chemotherapy (VEC regimen). <em>Krebsmedizin</em> 1991:12:3&#8211;14 [in
German].</li>

<li class="Ref">Nakachi K, Suemasu K, Suga K, et al. Influence of drinking green tea on breast
cancer malignancy among Japanese patients. <em>Jpn J Cancer Res</em>
1998;89:254&#8211;61.</li>

<li class="Ref">Nakachi K, Suemasu K, Suga K, et al. Influence of drinking green tea on breast
cancer malignancy among Japanese patients. <em>Jpn J Cancer Res</em>
1998;89:254&#8211;61.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cancer_Breast.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:24 GMT -->
</html>

